 Kristi Anseth
Concepts (703)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 164 | 2025 | 629 | 28.610 |
Why?
| | Polyethylene Glycols | 122 | 2025 | 587 | 19.130 |
Why?
| | Biocompatible Materials | 84 | 2024 | 388 | 12.440 |
Why?
| | Extracellular Matrix | 60 | 2025 | 502 | 10.540 |
Why?
| | Tissue Engineering | 56 | 2023 | 388 | 8.000 |
Why?
| | Cell Culture Techniques | 34 | 2023 | 336 | 6.470 |
Why?
| | Myofibroblasts | 18 | 2025 | 121 | 6.330 |
Why?
| | Aortic Valve | 24 | 2025 | 347 | 5.530 |
Why?
| | Chondrocytes | 24 | 2021 | 203 | 5.180 |
Why?
| | Polymers | 47 | 2024 | 477 | 4.960 |
Why?
| | Elasticity | 19 | 2024 | 194 | 4.820 |
Why?
| | Heart Valves | 14 | 2019 | 42 | 4.690 |
Why?
| | Mechanotransduction, Cellular | 10 | 2024 | 111 | 4.420 |
Why?
| | Sulfhydryl Compounds | 19 | 2024 | 187 | 4.400 |
Why?
| | Calcinosis | 12 | 2025 | 231 | 4.330 |
Why?
| | Fibroblasts | 21 | 2025 | 947 | 4.300 |
Why?
| | Cells, Cultured | 79 | 2025 | 4076 | 4.180 |
Why?
| | Cross-Linking Reagents | 35 | 2025 | 205 | 3.960 |
Why?
| | Organoids | 8 | 2023 | 104 | 3.760 |
Why?
| | Aortic Valve Stenosis | 9 | 2025 | 218 | 3.450 |
Why?
| | Osteogenesis | 15 | 2020 | 172 | 3.370 |
Why?
| | Cell Differentiation | 34 | 2024 | 1887 | 3.360 |
Why?
| | Oligopeptides | 19 | 2024 | 258 | 3.290 |
Why?
| | Tissue Scaffolds | 18 | 2024 | 201 | 3.120 |
Why?
| | Hydrazones | 7 | 2024 | 26 | 3.110 |
Why?
| | Cell Survival | 37 | 2024 | 1074 | 2.930 |
Why?
| | Swine | 35 | 2022 | 760 | 2.850 |
Why?
| | Click Chemistry | 10 | 2021 | 48 | 2.830 |
Why?
| | Photochemistry | 34 | 2021 | 132 | 2.820 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 70 | 2.750 |
Why?
| | Osteoblasts | 14 | 2025 | 116 | 2.730 |
Why?
| | Biomimetic Materials | 11 | 2018 | 69 | 2.580 |
Why?
| | Animals | 141 | 2025 | 35307 | 2.570 |
Why?
| | Cellular Microenvironment | 7 | 2022 | 81 | 2.320 |
Why?
| | Light | 22 | 2020 | 359 | 2.320 |
Why?
| | Photolysis | 10 | 2025 | 90 | 2.320 |
Why?
| | Peptides | 15 | 2015 | 923 | 2.160 |
Why?
| | Drug Delivery Systems | 15 | 2024 | 333 | 2.140 |
Why?
| | Cartilage | 13 | 2018 | 181 | 2.090 |
Why?
| | Materials Testing | 34 | 2019 | 343 | 2.070 |
Why?
| | Cell Adhesion | 22 | 2014 | 452 | 1.970 |
Why?
| | Cell Movement | 11 | 2024 | 944 | 1.930 |
Why?
| | Photochemical Processes | 13 | 2024 | 104 | 1.920 |
Why?
| | Transforming Growth Factor beta1 | 12 | 2020 | 157 | 1.860 |
Why?
| | Cell Communication | 10 | 2016 | 300 | 1.820 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 187 | 1.800 |
Why?
| | Acrylic Resins | 3 | 2025 | 44 | 1.780 |
Why?
| | Proteins | 7 | 2023 | 941 | 1.760 |
Why?
| | Matrix Metalloproteinases | 9 | 2017 | 90 | 1.710 |
Why?
| | Esters | 6 | 2025 | 73 | 1.710 |
Why?
| | Cartilage, Articular | 8 | 2021 | 292 | 1.680 |
Why?
| | Collagen | 14 | 2021 | 433 | 1.600 |
Why?
| | Actins | 16 | 2022 | 411 | 1.570 |
Why?
| | Intestines | 4 | 2023 | 347 | 1.560 |
Why?
| | Insulin-Secreting Cells | 7 | 2014 | 364 | 1.500 |
Why?
| | Microscopy | 2 | 2023 | 141 | 1.440 |
Why?
| | Myoblasts | 6 | 2024 | 81 | 1.390 |
Why?
| | Azides | 5 | 2022 | 46 | 1.360 |
Why?
| | Melanoma | 4 | 2021 | 729 | 1.350 |
Why?
| | Fibrosis | 8 | 2025 | 520 | 1.330 |
Why?
| | Hyaluronic Acid | 6 | 2024 | 214 | 1.330 |
Why?
| | Mice | 50 | 2024 | 16915 | 1.310 |
Why?
| | Paracrine Communication | 3 | 2020 | 61 | 1.270 |
Why?
| | Cells, Immobilized | 7 | 2018 | 21 | 1.230 |
Why?
| | Molecular Structure | 21 | 2018 | 478 | 1.220 |
Why?
| | Islets of Langerhans | 7 | 2010 | 789 | 1.180 |
Why?
| | Cadherins | 3 | 2022 | 188 | 1.180 |
Why?
| | Humans | 112 | 2025 | 129248 | 1.150 |
Why?
| | Signal Transduction | 15 | 2022 | 4926 | 1.140 |
Why?
| | Coated Materials, Biocompatible | 5 | 2011 | 59 | 1.140 |
Why?
| | Anhydrides | 8 | 2010 | 18 | 1.130 |
Why?
| | Extracellular Matrix Proteins | 4 | 2013 | 143 | 1.130 |
Why?
| | Polymerization | 7 | 2018 | 123 | 1.120 |
Why?
| | Phenotype | 12 | 2025 | 3074 | 1.120 |
Why?
| | Fibroblast Growth Factor 2 | 5 | 2008 | 82 | 1.120 |
Why?
| | Cell Line | 16 | 2025 | 2779 | 1.100 |
Why?
| | Viscosity | 5 | 2024 | 90 | 1.090 |
Why?
| | Cell Proliferation | 21 | 2025 | 2374 | 1.080 |
Why?
| | Elastic Modulus | 8 | 2017 | 122 | 1.070 |
Why?
| | Gels | 9 | 2008 | 81 | 1.070 |
Why?
| | Serum | 3 | 2022 | 58 | 1.070 |
Why?
| | Capsules | 7 | 2019 | 40 | 1.060 |
Why?
| | Indoles | 4 | 2017 | 384 | 1.060 |
Why?
| | Adaptor Proteins, Signal Transducing | 6 | 2021 | 399 | 1.060 |
Why?
| | Spheroids, Cellular | 3 | 2017 | 77 | 1.050 |
Why?
| | Integrins | 3 | 2024 | 94 | 1.030 |
Why?
| | Gene Expression | 9 | 2022 | 1466 | 1.020 |
Why?
| | Transforming Growth Factor beta | 6 | 2024 | 455 | 1.020 |
Why?
| | Sulfides | 4 | 2022 | 94 | 1.000 |
Why?
| | Islets of Langerhans Transplantation | 4 | 2010 | 63 | 0.980 |
Why?
| | Allyl Compounds | 3 | 2022 | 21 | 0.980 |
Why?
| | Acrylates | 11 | 2012 | 45 | 0.980 |
Why?
| | Sus scrofa | 6 | 2020 | 46 | 0.970 |
Why?
| | Triazoles | 2 | 2024 | 148 | 0.960 |
Why?
| | Heparin | 6 | 2010 | 253 | 0.940 |
Why?
| | Mechanical Phenomena | 3 | 2019 | 83 | 0.920 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 75 | 0.910 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2024 | 29 | 0.910 |
Why?
| | Actomyosin | 1 | 2024 | 17 | 0.890 |
Why?
| | Kinetics | 21 | 2020 | 1644 | 0.890 |
Why?
| | Vancomycin | 3 | 2010 | 77 | 0.890 |
Why?
| | Rheology | 7 | 2024 | 90 | 0.880 |
Why?
| | Heart Valve Diseases | 3 | 2014 | 152 | 0.880 |
Why?
| | Bone Regeneration | 4 | 2020 | 23 | 0.870 |
Why?
| | Collagenases | 3 | 2015 | 23 | 0.870 |
Why?
| | Regenerative Medicine | 2 | 2017 | 45 | 0.850 |
Why?
| | Polyesters | 6 | 2009 | 71 | 0.840 |
Why?
| | Norbornanes | 3 | 2013 | 15 | 0.830 |
Why?
| | Bone Substitutes | 5 | 2019 | 25 | 0.830 |
Why?
| | Delayed-Action Preparations | 10 | 2018 | 172 | 0.820 |
Why?
| | Sulfonamides | 3 | 2017 | 495 | 0.800 |
Why?
| | Alkynes | 5 | 2022 | 54 | 0.780 |
Why?
| | Peptide Fragments | 4 | 2013 | 692 | 0.780 |
Why?
| | Genes, X-Linked | 1 | 2022 | 17 | 0.770 |
Why?
| | Podosomes | 1 | 2021 | 3 | 0.760 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 23 | 0.760 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2022 | 39 | 0.760 |
Why?
| | Rats | 26 | 2022 | 5482 | 0.760 |
Why?
| | Cattle | 19 | 2018 | 977 | 0.760 |
Why?
| | Fibronectins | 7 | 2012 | 123 | 0.750 |
Why?
| | Stress, Mechanical | 9 | 2021 | 467 | 0.740 |
Why?
| | Skull | 5 | 2012 | 129 | 0.740 |
Why?
| | Elastomers | 1 | 2021 | 25 | 0.730 |
Why?
| | NIH 3T3 Cells | 11 | 2020 | 140 | 0.720 |
Why?
| | Coculture Techniques | 7 | 2024 | 223 | 0.720 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1202 | 0.720 |
Why?
| | Chondrogenesis | 4 | 2011 | 82 | 0.720 |
Why?
| | Intestinal Mucosa | 5 | 2023 | 589 | 0.710 |
Why?
| | Dexamethasone | 4 | 2013 | 350 | 0.710 |
Why?
| | Bone and Bones | 5 | 2019 | 295 | 0.700 |
Why?
| | Mechanoreceptors | 1 | 2020 | 16 | 0.690 |
Why?
| | Myocytes, Cardiac | 5 | 2020 | 499 | 0.690 |
Why?
| | Calcium Signaling | 2 | 2020 | 250 | 0.690 |
Why?
| | Inflammation Mediators | 2 | 2020 | 505 | 0.680 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 100 | 0.680 |
Why?
| | Models, Biological | 9 | 2024 | 1722 | 0.670 |
Why?
| | Fluorescent Dyes | 5 | 2015 | 312 | 0.670 |
Why?
| | Regeneration | 4 | 2016 | 181 | 0.660 |
Why?
| | Tumor Microenvironment | 4 | 2024 | 631 | 0.660 |
Why?
| | Drug Carriers | 7 | 2017 | 119 | 0.650 |
Why?
| | Phosphates | 3 | 2012 | 179 | 0.650 |
Why?
| | Models, Chemical | 8 | 2009 | 262 | 0.650 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.640 |
Why?
| | Methacrylates | 6 | 2012 | 112 | 0.630 |
Why?
| | Osteoporosis | 1 | 2022 | 229 | 0.630 |
Why?
| | Proteoglycans | 3 | 2013 | 109 | 0.620 |
Why?
| | Azo Compounds | 2 | 2018 | 26 | 0.620 |
Why?
| | Biophysics | 1 | 2019 | 68 | 0.620 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.610 |
Why?
| | Viscoelastic Substances | 2 | 2020 | 10 | 0.610 |
Why?
| | Aza Compounds | 1 | 2018 | 13 | 0.610 |
Why?
| | Surface Properties | 12 | 2012 | 397 | 0.600 |
Why?
| | Lactic Acid | 6 | 2016 | 298 | 0.600 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 256 | 0.600 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 400 | 0.580 |
Why?
| | Precision Medicine | 2 | 2022 | 386 | 0.580 |
Why?
| | Transcriptome | 5 | 2022 | 874 | 0.580 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 209 | 0.570 |
Why?
| | Alkaline Phosphatase | 8 | 2016 | 146 | 0.570 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 121 | 0.570 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3201 | 0.560 |
Why?
| | Molecular Probes | 1 | 2017 | 37 | 0.560 |
Why?
| | Myocardium | 5 | 2024 | 978 | 0.550 |
Why?
| | Nanoparticles | 3 | 2018 | 375 | 0.540 |
Why?
| | Insulin | 9 | 2014 | 2325 | 0.540 |
Why?
| | Cycloaddition Reaction | 6 | 2024 | 27 | 0.530 |
Why?
| | Antigens | 3 | 2013 | 356 | 0.530 |
Why?
| | Biopolymers | 3 | 2022 | 32 | 0.530 |
Why?
| | Apoptosis | 10 | 2017 | 2498 | 0.520 |
Why?
| | DNA | 6 | 2006 | 1396 | 0.520 |
Why?
| | Macromolecular Substances | 3 | 2017 | 216 | 0.520 |
Why?
| | Lipase | 2 | 2007 | 65 | 0.510 |
Why?
| | Cell Self Renewal | 1 | 2016 | 53 | 0.510 |
Why?
| | Polyvinyl Alcohol | 5 | 2002 | 14 | 0.510 |
Why?
| | Amino Acid Sequence | 7 | 2015 | 2056 | 0.510 |
Why?
| | Gene Expression Regulation | 8 | 2022 | 2537 | 0.500 |
Why?
| | Microspheres | 2 | 2015 | 124 | 0.490 |
Why?
| | 3T3 Cells | 5 | 2012 | 153 | 0.490 |
Why?
| | Muscle, Smooth | 4 | 2009 | 157 | 0.490 |
Why?
| | Microarray Analysis | 1 | 2015 | 117 | 0.480 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 63 | 0.480 |
Why?
| | Niacinamide | 1 | 2015 | 75 | 0.460 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 89 | 0.460 |
Why?
| | Rats, Sprague-Dawley | 11 | 2022 | 2396 | 0.450 |
Why?
| | Solubility | 5 | 2020 | 232 | 0.450 |
Why?
| | Macrophages | 2 | 2020 | 1484 | 0.450 |
Why?
| | Immobilized Proteins | 1 | 2014 | 10 | 0.440 |
Why?
| | Immunohistochemistry | 7 | 2022 | 1691 | 0.440 |
Why?
| | Microscopy, Confocal | 4 | 2012 | 305 | 0.440 |
Why?
| | Factor XIIIa | 1 | 2013 | 5 | 0.440 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 890 | 0.430 |
Why?
| | Antibodies | 2 | 2006 | 398 | 0.430 |
Why?
| | Cell Engineering | 1 | 2013 | 9 | 0.430 |
Why?
| | Mammals | 3 | 2023 | 272 | 0.430 |
Why?
| | Biochemistry | 1 | 2014 | 38 | 0.430 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 389 | 0.430 |
Why?
| | Prostheses and Implants | 5 | 2009 | 130 | 0.430 |
Why?
| | Serum Albumin, Bovine | 2 | 2018 | 63 | 0.420 |
Why?
| | Microfluidics | 3 | 2010 | 52 | 0.420 |
Why?
| | beta Catenin | 1 | 2015 | 223 | 0.410 |
Why?
| | Epithelial Cells | 4 | 2022 | 1063 | 0.410 |
Why?
| | Compressive Strength | 5 | 2021 | 69 | 0.410 |
Why?
| | Orthopedics | 4 | 2007 | 135 | 0.410 |
Why?
| | Stem Cells | 3 | 2022 | 574 | 0.400 |
Why?
| | Polystyrenes | 5 | 2014 | 37 | 0.400 |
Why?
| | Nanocapsules | 1 | 2012 | 10 | 0.400 |
Why?
| | Biomarkers | 5 | 2022 | 3966 | 0.400 |
Why?
| | Cytokines | 1 | 2020 | 2013 | 0.390 |
Why?
| | Leukocyte Elastase | 2 | 2009 | 74 | 0.390 |
Why?
| | Time Factors | 14 | 2011 | 6543 | 0.390 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2018 | 72 | 0.390 |
Why?
| | Molecular Weight | 5 | 2014 | 328 | 0.380 |
Why?
| | Disease Progression | 3 | 2021 | 2630 | 0.380 |
Why?
| | Muscle Contraction | 3 | 2024 | 422 | 0.370 |
Why?
| | Biomechanical Phenomena | 6 | 2017 | 757 | 0.370 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 327 | 0.370 |
Why?
| | Cardiomegaly | 2 | 2024 | 172 | 0.370 |
Why?
| | Nerve Net | 1 | 2014 | 260 | 0.370 |
Why?
| | Embryonic Stem Cells | 2 | 2014 | 114 | 0.360 |
Why?
| | Awards and Prizes | 1 | 2012 | 63 | 0.360 |
Why?
| | TRPV Cation Channels | 2 | 2022 | 36 | 0.360 |
Why?
| | Tensile Strength | 5 | 2025 | 93 | 0.360 |
Why?
| | Gelatin | 2 | 2017 | 42 | 0.360 |
Why?
| | Endothelial Cells | 2 | 2014 | 746 | 0.360 |
Why?
| | Printing, Three-Dimensional | 2 | 2022 | 88 | 0.360 |
Why?
| | Culture Media | 4 | 2014 | 160 | 0.350 |
Why?
| | MAP Kinase Signaling System | 3 | 2021 | 313 | 0.350 |
Why?
| | Metalloporphyrins | 1 | 2011 | 101 | 0.350 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 947 | 0.350 |
Why?
| | Superoxides | 1 | 2011 | 201 | 0.350 |
Why?
| | Titanium | 2 | 2010 | 76 | 0.350 |
Why?
| | Collagen Type I | 4 | 2020 | 118 | 0.350 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 153 | 0.340 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2010 | 16 | 0.340 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 75 | 0.340 |
Why?
| | Fibrosarcoma | 1 | 2009 | 21 | 0.330 |
Why?
| | Phosphinic Acids | 1 | 2009 | 9 | 0.330 |
Why?
| | fas Receptor | 1 | 2010 | 95 | 0.330 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1702 | 0.330 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2009 | 537 | 0.320 |
Why?
| | Equipment Design | 4 | 2017 | 513 | 0.320 |
Why?
| | Heart Defects, Congenital | 2 | 2014 | 757 | 0.320 |
Why?
| | Parathyroid Hormone | 2 | 2020 | 106 | 0.320 |
Why?
| | Pravastatin | 1 | 2009 | 40 | 0.320 |
Why?
| | Phosphoproteins | 3 | 2017 | 332 | 0.320 |
Why?
| | Recombinant Proteins | 5 | 2012 | 1304 | 0.320 |
Why?
| | Transcription Factors | 4 | 2021 | 1647 | 0.320 |
Why?
| | Cardiomyopathies | 1 | 2013 | 340 | 0.320 |
Why?
| | Plasmids | 4 | 2007 | 358 | 0.320 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 118 | 0.320 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2835 | 0.310 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2009 | 49 | 0.310 |
Why?
| | Sex Characteristics | 3 | 2025 | 736 | 0.310 |
Why?
| | Heart Valve Prosthesis | 3 | 2005 | 112 | 0.310 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 342 | 0.310 |
Why?
| | Enzymes | 1 | 2009 | 65 | 0.310 |
Why?
| | Bioprinting | 2 | 2022 | 24 | 0.310 |
Why?
| | Trans-Activators | 3 | 2021 | 388 | 0.300 |
Why?
| | Dendritic Cells | 1 | 2012 | 479 | 0.300 |
Why?
| | In Vitro Techniques | 5 | 2014 | 1085 | 0.300 |
Why?
| | Protein Engineering | 2 | 2008 | 106 | 0.300 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 112 | 0.300 |
Why?
| | Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.300 |
Why?
| | Hemodynamics | 1 | 2013 | 1090 | 0.290 |
Why?
| | Cell Division | 5 | 2004 | 796 | 0.290 |
Why?
| | High-Throughput Screening Assays | 2 | 2025 | 138 | 0.290 |
Why?
| | Transfection | 5 | 2011 | 915 | 0.290 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1933 | 0.290 |
Why?
| | Protein Binding | 6 | 2010 | 2120 | 0.290 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 483 | 0.290 |
Why?
| | Smad Proteins | 1 | 2008 | 38 | 0.290 |
Why?
| | Glucose Oxidase | 4 | 2011 | 26 | 0.290 |
Why?
| | Microscopy, Electron, Scanning | 7 | 2012 | 196 | 0.290 |
Why?
| | Glucocorticoids | 1 | 2012 | 578 | 0.290 |
Why?
| | Biofilms | 1 | 2010 | 243 | 0.290 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 616 | 0.280 |
Why?
| | Bone Cements | 2 | 2010 | 41 | 0.280 |
Why?
| | Ultraviolet Rays | 5 | 2009 | 382 | 0.280 |
Why?
| | Glucose | 6 | 2014 | 1001 | 0.270 |
Why?
| | Anoikis | 1 | 2007 | 31 | 0.270 |
Why?
| | Collagen Type II | 4 | 2009 | 48 | 0.270 |
Why?
| | Temperature | 5 | 2013 | 634 | 0.270 |
Why?
| | Aorta | 1 | 2009 | 408 | 0.270 |
Why?
| | Shear Strength | 2 | 2020 | 67 | 0.270 |
Why?
| | Students | 1 | 2012 | 579 | 0.260 |
Why?
| | Growth Substances | 3 | 2003 | 150 | 0.260 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 52 | 0.260 |
Why?
| | Adsorption | 4 | 2012 | 139 | 0.260 |
Why?
| | Cell Shape | 3 | 2022 | 54 | 0.250 |
Why?
| | Nerve Tissue | 1 | 2005 | 4 | 0.250 |
Why?
| | Biology | 2 | 2017 | 84 | 0.250 |
Why?
| | Cell Nucleus | 2 | 2020 | 586 | 0.250 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 39 | 0.250 |
Why?
| | Extracellular Fluid | 1 | 2005 | 31 | 0.240 |
Why?
| | Porosity | 2 | 2019 | 92 | 0.240 |
Why?
| | Biodegradation, Environmental | 6 | 2003 | 80 | 0.240 |
Why?
| | Staining and Labeling | 3 | 2015 | 141 | 0.240 |
Why?
| | Carbonates | 1 | 2025 | 10 | 0.240 |
Why?
| | Chromosomes, Human, Y | 1 | 2025 | 20 | 0.240 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2005 | 15 | 0.240 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 430 | 0.240 |
Why?
| | Cell Separation | 2 | 2018 | 316 | 0.240 |
Why?
| | Bioprosthesis | 1 | 2005 | 40 | 0.240 |
Why?
| | Microscopy, Atomic Force | 3 | 2017 | 116 | 0.230 |
Why?
| | PAX7 Transcription Factor | 1 | 2024 | 13 | 0.230 |
Why?
| | Calcium | 4 | 2024 | 1212 | 0.230 |
Why?
| | Carbamates | 1 | 2025 | 46 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 833 | 0.230 |
Why?
| | Organophosphates | 1 | 2005 | 120 | 0.230 |
Why?
| | Ultrasonography | 1 | 2008 | 713 | 0.230 |
Why?
| | Polyanhydrides | 1 | 2004 | 2 | 0.230 |
Why?
| | MicroRNAs | 1 | 2011 | 676 | 0.230 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 12 | 0.230 |
Why?
| | Primary Cell Culture | 3 | 2016 | 160 | 0.230 |
Why?
| | Cell Membrane | 3 | 2013 | 732 | 0.230 |
Why?
| | Vesiculovirus | 1 | 2024 | 16 | 0.220 |
Why?
| | Anisotropy | 1 | 2024 | 73 | 0.220 |
Why?
| | Diffusion | 4 | 2009 | 116 | 0.220 |
Why?
| | Boidae | 1 | 2024 | 20 | 0.220 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 81 | 0.220 |
Why?
| | Cell Transplantation | 1 | 2003 | 37 | 0.220 |
Why?
| | Nitrites | 1 | 2004 | 83 | 0.220 |
Why?
| | Azacitidine | 1 | 2025 | 139 | 0.220 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2017 | 107 | 0.210 |
Why?
| | Drug Design | 3 | 2012 | 156 | 0.210 |
Why?
| | Cell Cycle | 2 | 2019 | 589 | 0.210 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3079 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2012 | 398 | 0.210 |
Why?
| | Aldehydes | 2 | 2014 | 142 | 0.210 |
Why?
| | Endoglin | 2 | 2016 | 19 | 0.210 |
Why?
| | Male | 17 | 2025 | 63501 | 0.210 |
Why?
| | Annexin A2 | 1 | 2022 | 10 | 0.200 |
Why?
| | Butadienes | 1 | 2003 | 36 | 0.200 |
Why?
| | Weight-Bearing | 1 | 2004 | 162 | 0.200 |
Why?
| | Laminin | 3 | 2008 | 69 | 0.200 |
Why?
| | Axons | 2 | 2014 | 191 | 0.200 |
Why?
| | Calcification, Physiologic | 1 | 2002 | 33 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2012 | 2008 | 0.200 |
Why?
| | Hydrolysis | 5 | 2025 | 186 | 0.200 |
Why?
| | Mice, Inbred BALB C | 3 | 2010 | 1247 | 0.200 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 25 | 0.200 |
Why?
| | Particle Size | 4 | 2012 | 352 | 0.190 |
Why?
| | Neurons | 3 | 2010 | 1494 | 0.190 |
Why?
| | Receptors, Cell Surface | 3 | 2008 | 380 | 0.190 |
Why?
| | Interstitial Cells of Cajal | 2 | 2019 | 4 | 0.190 |
Why?
| | Morphogenesis | 1 | 2023 | 158 | 0.190 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1688 | 0.190 |
Why?
| | Sex Factors | 3 | 2022 | 1965 | 0.180 |
Why?
| | Robotics | 1 | 2023 | 93 | 0.180 |
Why?
| | Mice, Nude | 4 | 2015 | 682 | 0.180 |
Why?
| | Ovariectomy | 1 | 2022 | 135 | 0.180 |
Why?
| | Osteopontin | 3 | 2006 | 31 | 0.180 |
Why?
| | Organogenesis | 1 | 2022 | 56 | 0.180 |
Why?
| | Isoelectric Point | 1 | 2021 | 23 | 0.180 |
Why?
| | Drug Compounding | 4 | 2005 | 97 | 0.180 |
Why?
| | Base Sequence | 4 | 2012 | 2146 | 0.180 |
Why?
| | Vinculin | 2 | 2013 | 10 | 0.180 |
Why?
| | Temporomandibular Joint | 1 | 2001 | 8 | 0.180 |
Why?
| | Glycosaminoglycans | 4 | 2008 | 84 | 0.180 |
Why?
| | Focal Adhesions | 2 | 2015 | 44 | 0.180 |
Why?
| | Sialoglycoproteins | 3 | 2006 | 155 | 0.180 |
Why?
| | Membrane Proteins | 2 | 2020 | 1117 | 0.180 |
Why?
| | Isoproterenol | 1 | 2021 | 115 | 0.180 |
Why?
| | Muramidase | 2 | 2012 | 77 | 0.180 |
Why?
| | Secretory Pathway | 1 | 2020 | 7 | 0.180 |
Why?
| | THP-1 Cells | 1 | 2020 | 22 | 0.180 |
Why?
| | Tricarboxylic Acids | 1 | 2000 | 10 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 742 | 0.170 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2021 | 127 | 0.170 |
Why?
| | Chromatography, Gel | 3 | 2007 | 126 | 0.170 |
Why?
| | Bacterial Adhesion | 2 | 2012 | 91 | 0.170 |
Why?
| | Hydroxamic Acids | 1 | 2020 | 88 | 0.170 |
Why?
| | Viral Proteins | 2 | 2024 | 327 | 0.170 |
Why?
| | Wound Healing | 4 | 2022 | 305 | 0.170 |
Why?
| | Fluoresceins | 2 | 2012 | 47 | 0.170 |
Why?
| | DNA Methylation | 1 | 2025 | 610 | 0.160 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2017 | 119 | 0.160 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 31 | 0.160 |
Why?
| | Hexanes | 1 | 1999 | 4 | 0.160 |
Why?
| | Dicarboxylic Acids | 1 | 1999 | 6 | 0.160 |
Why?
| | Acetylation | 1 | 2020 | 244 | 0.160 |
Why?
| | DNA Primers | 3 | 2012 | 510 | 0.160 |
Why?
| | Adipogenesis | 2 | 2011 | 50 | 0.160 |
Why?
| | Boronic Acids | 1 | 2019 | 37 | 0.160 |
Why?
| | Ligands | 2 | 2014 | 621 | 0.160 |
Why?
| | Bone Diseases | 1 | 2019 | 57 | 0.160 |
Why?
| | Antibodies, Immobilized | 1 | 2018 | 1 | 0.160 |
Why?
| | Isomerism | 2 | 2018 | 53 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 212 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 209 | 0.150 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2010 | 65 | 0.150 |
Why?
| | Bioengineering | 1 | 2018 | 19 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 431 | 0.150 |
Why?
| | Phenylacetates | 1 | 2018 | 9 | 0.150 |
Why?
| | Female | 13 | 2025 | 68543 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 81 | 0.150 |
Why?
| | DNA Ligases | 1 | 2018 | 7 | 0.150 |
Why?
| | Jurkat Cells | 2 | 2010 | 134 | 0.150 |
Why?
| | Gold | 1 | 2019 | 118 | 0.150 |
Why?
| | Bacteriophage T4 | 1 | 2018 | 15 | 0.150 |
Why?
| | Absorbable Implants | 2 | 2009 | 35 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2017 | 131 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 70 | 0.150 |
Why?
| | Chemotaxis | 2 | 2009 | 129 | 0.140 |
Why?
| | beta-Cyclodextrins | 1 | 2018 | 27 | 0.140 |
Why?
| | Dendrimers | 1 | 2017 | 13 | 0.140 |
Why?
| | Absorption | 2 | 2009 | 57 | 0.140 |
Why?
| | A549 Cells | 1 | 2017 | 59 | 0.140 |
Why?
| | Animals, Newborn | 3 | 2006 | 834 | 0.140 |
Why?
| | Heart Diseases | 1 | 2021 | 350 | 0.140 |
Why?
| | Periodicals as Topic | 2 | 2017 | 204 | 0.140 |
Why?
| | Substrate Specificity | 2 | 2009 | 368 | 0.140 |
Why?
| | Heart | 1 | 2021 | 637 | 0.140 |
Why?
| | Biomimetics | 1 | 2017 | 42 | 0.140 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 42 | 0.140 |
Why?
| | Biomedical Engineering | 4 | 2001 | 25 | 0.140 |
Why?
| | Enzyme Stability | 2 | 2018 | 69 | 0.130 |
Why?
| | Rubber | 1 | 1996 | 6 | 0.130 |
Why?
| | Culture Media, Serum-Free | 2 | 2007 | 49 | 0.130 |
Why?
| | Elastin | 2 | 2008 | 77 | 0.130 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 476 | 0.130 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 158 | 0.130 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2017 | 192 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2008 | 541 | 0.130 |
Why?
| | Maleimides | 2 | 2013 | 21 | 0.130 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 308 | 0.130 |
Why?
| | Furans | 2 | 2013 | 23 | 0.130 |
Why?
| | Nanomedicine | 1 | 2016 | 32 | 0.120 |
Why?
| | Stromal Cells | 1 | 2015 | 105 | 0.120 |
Why?
| | Hot Temperature | 1 | 2018 | 369 | 0.120 |
Why?
| | Composite Resins | 1 | 1996 | 109 | 0.120 |
Why?
| | Structure-Activity Relationship | 2 | 2009 | 543 | 0.120 |
Why?
| | Models, Theoretical | 4 | 2007 | 546 | 0.120 |
Why?
| | Histones | 1 | 2020 | 588 | 0.120 |
Why?
| | Medicine | 1 | 2017 | 119 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2022 | 4057 | 0.110 |
Why?
| | Ethylene Glycols | 3 | 2000 | 15 | 0.110 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2004 | 26 | 0.110 |
Why?
| | Computational Biology | 2 | 2022 | 595 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 442 | 0.110 |
Why?
| | Cell-Matrix Junctions | 1 | 2014 | 3 | 0.110 |
Why?
| | Cytostatic Agents | 1 | 2014 | 6 | 0.110 |
Why?
| | Streptavidin | 1 | 2014 | 14 | 0.110 |
Why?
| | Glass | 1 | 2014 | 43 | 0.110 |
Why?
| | Integrin beta1 | 1 | 2013 | 22 | 0.110 |
Why?
| | Acyltransferases | 1 | 2014 | 55 | 0.110 |
Why?
| | Benzaldehydes | 1 | 2013 | 10 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2013 | 38 | 0.110 |
Why?
| | Cyclization | 2 | 2011 | 16 | 0.110 |
Why?
| | Basal Metabolism | 1 | 2014 | 58 | 0.110 |
Why?
| | Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.110 |
Why?
| | CD146 Antigen | 1 | 2013 | 41 | 0.110 |
Why?
| | Benzoquinones | 1 | 2014 | 48 | 0.110 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 64 | 0.110 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 175 | 0.110 |
Why?
| | Coloring Agents | 1 | 2013 | 77 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 2 | 0.110 |
Why?
| | Muscle Cells | 1 | 2013 | 42 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 55 | 0.100 |
Why?
| | Decanoic Acids | 2 | 2005 | 8 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 203 | 0.100 |
Why?
| | Gelatin Sponge, Absorbable | 1 | 2012 | 5 | 0.100 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.100 |
Why?
| | Developmental Biology | 1 | 2012 | 22 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 328 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2013 | 127 | 0.100 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 44 | 0.100 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 133 | 0.100 |
Why?
| | Ethers | 1 | 2012 | 16 | 0.100 |
Why?
| | Connective Tissue Growth Factor | 1 | 2012 | 24 | 0.100 |
Why?
| | Biofouling | 1 | 2012 | 9 | 0.100 |
Why?
| | Fracture Healing | 1 | 2012 | 75 | 0.100 |
Why?
| | Systems Biology | 1 | 2012 | 59 | 0.100 |
Why?
| | Free Radicals | 1 | 2012 | 105 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 756 | 0.100 |
Why?
| | Crystallization | 2 | 2009 | 138 | 0.090 |
Why?
| | Bone Transplantation | 1 | 2012 | 83 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 360 | 0.090 |
Why?
| | China | 1 | 2012 | 192 | 0.090 |
Why?
| | Receptor, EphA5 | 1 | 2011 | 1 | 0.090 |
Why?
| | Ephrin-A5 | 1 | 2011 | 1 | 0.090 |
Why?
| | Thermodynamics | 1 | 2013 | 406 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2013 | 261 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1204 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 374 | 0.090 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 39 | 0.090 |
Why?
| | Half-Life | 1 | 2011 | 162 | 0.090 |
Why?
| | Homeostasis | 1 | 2014 | 605 | 0.090 |
Why?
| | Biological Availability | 1 | 2011 | 147 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1288 | 0.090 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 88 | 0.090 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 17 | 0.090 |
Why?
| | Ascorbic Acid | 1 | 2011 | 120 | 0.090 |
Why?
| | Heparin Lyase | 1 | 2010 | 5 | 0.090 |
Why?
| | Carbohydrate Sequence | 1 | 2010 | 24 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 21 | 0.090 |
Why?
| | Flow Cytometry | 2 | 2011 | 1155 | 0.090 |
Why?
| | Copper | 1 | 2011 | 107 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 588 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2012 | 300 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 635 | 0.080 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.080 |
Why?
| | Polymethacrylic Acids | 2 | 2003 | 62 | 0.080 |
Why?
| | Enzyme Assays | 1 | 2009 | 25 | 0.080 |
Why?
| | Decorin | 1 | 2009 | 7 | 0.080 |
Why?
| | Lithium | 1 | 2009 | 37 | 0.080 |
Why?
| | Biochemical Phenomena | 1 | 2009 | 10 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 118 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2009 | 70 | 0.080 |
Why?
| | Cloning, Molecular | 1 | 2010 | 525 | 0.080 |
Why?
| | Acrylamides | 1 | 2009 | 57 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2007 | 130 | 0.080 |
Why?
| | Keratinocytes | 1 | 2010 | 242 | 0.080 |
Why?
| | Biotechnology | 1 | 2009 | 39 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2003 | 0.080 |
Why?
| | Fibroblast Growth Factors | 1 | 2010 | 169 | 0.080 |
Why?
| | Computer Simulation | 2 | 2013 | 939 | 0.080 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 213 | 0.080 |
Why?
| | Culture Techniques | 1 | 2008 | 81 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 195 | 0.080 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 94 | 0.080 |
Why?
| | Serum Albumin | 1 | 2009 | 148 | 0.080 |
Why?
| | Microchemistry | 1 | 2008 | 20 | 0.080 |
Why?
| | Probability | 1 | 2009 | 305 | 0.080 |
Why?
| | Ultrasonics | 1 | 2008 | 49 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2449 | 0.070 |
Why?
| | Integrin alpha5beta1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2008 | 23 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 648 | 0.070 |
Why?
| | Integrin alphaVbeta3 | 1 | 2008 | 19 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 68 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2008 | 84 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 347 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1109 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 5439 | 0.070 |
Why?
| | Lasers | 1 | 2008 | 132 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2009 | 3628 | 0.070 |
Why?
| | Drug Stability | 2 | 2005 | 159 | 0.070 |
Why?
| | Aggrecans | 1 | 2007 | 14 | 0.070 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2007 | 21 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 283 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 59 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 591 | 0.070 |
Why?
| | Hepatocyte Growth Factor | 1 | 2007 | 34 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 854 | 0.070 |
Why?
| | Calorimetry, Differential Scanning | 3 | 2005 | 36 | 0.070 |
Why?
| | Bioreactors | 1 | 2006 | 42 | 0.070 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 52 | 0.060 |
Why?
| | Environment | 1 | 2008 | 344 | 0.060 |
Why?
| | Water | 1 | 2009 | 440 | 0.060 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2007 | 164 | 0.060 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 17 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2342 | 0.060 |
Why?
| | Nanotechnology | 1 | 2007 | 122 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1837 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2005 | 23 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2053 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1036 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 83 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2007 | 311 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 489 | 0.060 |
Why?
| | Ear, External | 1 | 2005 | 24 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 812 | 0.060 |
Why?
| | Thiazoles | 1 | 2005 | 117 | 0.060 |
Why?
| | Facial Bones | 1 | 2005 | 28 | 0.060 |
Why?
| | Glucagon | 1 | 2005 | 105 | 0.060 |
Why?
| | Nasal Septum | 1 | 2005 | 25 | 0.060 |
Why?
| | Immunoblotting | 1 | 2005 | 305 | 0.060 |
Why?
| | Cell Count | 1 | 2005 | 311 | 0.060 |
Why?
| | Nose | 1 | 2005 | 63 | 0.060 |
Why?
| | Larynx | 1 | 2005 | 57 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.060 |
Why?
| | Hexuronic Acids | 1 | 2004 | 23 | 0.060 |
Why?
| | Glucuronic Acid | 1 | 2004 | 25 | 0.060 |
Why?
| | MCF-7 Cells | 1 | 2024 | 116 | 0.060 |
Why?
| | Methylation | 1 | 2025 | 230 | 0.060 |
Why?
| | Sheep | 1 | 2007 | 838 | 0.060 |
Why?
| | Myofibrils | 1 | 2024 | 49 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2005 | 183 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2005 | 183 | 0.060 |
Why?
| | Alginates | 1 | 2004 | 46 | 0.060 |
Why?
| | Photography | 1 | 2004 | 93 | 0.060 |
Why?
| | Cell Size | 1 | 2004 | 87 | 0.050 |
Why?
| | Postprandial Period | 1 | 2024 | 104 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2009 | 803 | 0.050 |
Why?
| | Catalysis | 2 | 2017 | 307 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1613 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2024 | 81 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2005 | 135 | 0.050 |
Why?
| | Trachea | 1 | 2005 | 220 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 161 | 0.050 |
Why?
| | Cystatin C | 1 | 2022 | 65 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1000 | 0.050 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 1028 | 0.050 |
Why?
| | Somatomedins | 1 | 2002 | 28 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 338 | 0.050 |
Why?
| | Polyvinyls | 1 | 2002 | 18 | 0.050 |
Why?
| | Biomarkers, Pharmacological | 1 | 2022 | 26 | 0.050 |
Why?
| | Injections | 1 | 2002 | 174 | 0.050 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 129 | 0.050 |
Why?
| | Technology, Pharmaceutical | 1 | 2002 | 20 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 22 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2023 | 181 | 0.050 |
Why?
| | Paneth Cells | 1 | 2022 | 16 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2022 | 74 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2003 | 288 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2010 | 5736 | 0.050 |
Why?
| | Cicatrix | 1 | 2022 | 59 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 696 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 84 | 0.050 |
Why?
| | Receptors, Notch | 1 | 2022 | 84 | 0.050 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2001 | 8 | 0.050 |
Why?
| | Chlorobenzenes | 1 | 2001 | 9 | 0.040 |
Why?
| | Succinimides | 1 | 2001 | 17 | 0.040 |
Why?
| | Femur | 2 | 2019 | 243 | 0.040 |
Why?
| | Polyglycolic Acid | 1 | 2001 | 39 | 0.040 |
Why?
| | Chromosomes | 1 | 2021 | 100 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2004 | 706 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 513 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 132 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 136 | 0.040 |
Why?
| | Lung | 1 | 2013 | 3926 | 0.040 |
Why?
| | Mathematical Computing | 1 | 2000 | 11 | 0.040 |
Why?
| | Fumarates | 1 | 2019 | 8 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 131 | 0.040 |
Why?
| | Polypropylenes | 1 | 2019 | 14 | 0.040 |
Why?
| | Ursidae | 1 | 2019 | 7 | 0.040 |
Why?
| | Lipids | 1 | 2003 | 625 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 132 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 321 | 0.040 |
Why?
| | Blood Proteins | 1 | 2001 | 244 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1367 | 0.040 |
Why?
| | Mitochondria | 1 | 2005 | 877 | 0.040 |
Why?
| | Models, Genetic | 1 | 2022 | 593 | 0.040 |
Why?
| | Spectrophotometry, Infrared | 1 | 1999 | 54 | 0.040 |
Why?
| | Intracellular Space | 1 | 2019 | 69 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 873 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 458 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2737 | 0.040 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2018 | 37 | 0.040 |
Why?
| | Drug Liberation | 1 | 2018 | 30 | 0.040 |
Why?
| | Prosthesis Implantation | 1 | 1999 | 143 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 428 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2004 | 2703 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 942 | 0.030 |
Why?
| | Quality Control | 1 | 1996 | 163 | 0.030 |
Why?
| | Ketanserin | 1 | 1996 | 12 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1835 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1054 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 584 | 0.030 |
Why?
| | Sclerosis | 1 | 2014 | 12 | 0.030 |
Why?
| | Collagen Type III | 1 | 2014 | 14 | 0.030 |
Why?
| | Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| | Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2013 | 15 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2013 | 21 | 0.030 |
Why?
| | Exocytosis | 1 | 2014 | 88 | 0.030 |
Why?
| | Myosins | 1 | 2013 | 133 | 0.030 |
Why?
| | Cell Polarity | 1 | 2013 | 139 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 867 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 155 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 442 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1021 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 184 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1613 | 0.020 |
Why?
| | Ear Cartilage | 1 | 2010 | 3 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1584 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 263 | 0.020 |
Why?
| | Skin | 2 | 2010 | 726 | 0.020 |
Why?
| | Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| | Keratin-14 | 1 | 2010 | 14 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 2011 | 29 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 637 | 0.020 |
Why?
| | Dermis | 1 | 2010 | 31 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 313 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 347 | 0.020 |
Why?
| | Physical Phenomena | 1 | 2009 | 13 | 0.020 |
Why?
| | Amino Acids | 1 | 2013 | 486 | 0.020 |
Why?
| | Dimerization | 2 | 1999 | 191 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 332 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 766 | 0.020 |
Why?
| | Buffers | 1 | 2007 | 56 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 111 | 0.020 |
Why?
| | Nanocomposites | 1 | 2007 | 14 | 0.020 |
Why?
| | Skull Fractures | 1 | 2007 | 33 | 0.020 |
Why?
| | Protons | 1 | 2007 | 80 | 0.020 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.020 |
Why?
| | Chemical Precipitation | 1 | 2005 | 37 | 0.020 |
Why?
| | Powders | 1 | 2005 | 43 | 0.020 |
Why?
| | Excipients | 1 | 2005 | 52 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 385 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 10199 | 0.010 |
Why?
| | Solutions | 1 | 2004 | 150 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 623 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 227 | 0.010 |
Why?
| | Patella | 1 | 2000 | 22 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1204 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1999 | 147 | 0.010 |
Why?
| | Adhesiveness | 1 | 1996 | 19 | 0.010 |
Why?
| | Freezing | 1 | 1996 | 85 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 70 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|